Business Description
Enzymatica AB
ISIN : SE0003943620
Compare
Compare
Traded in other countries / regions
ENZY.SwedenEN9.Germany IPO Date
2020-07-21Description
Enzymatica AB is a life science company that develops and sells medical devices against infectious diseases, based on a barrier technology, which includes marine enzymes. Its product ColdZyme Mouth Spray prevents cold and reduces disease period.
Financial Strength
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 79.82 | |||||
| Equity-to-Asset | 0.89 | |||||
| Debt-to-Equity | 0.01 | |||||
| Debt-to-EBITDA | -0.02 | |||||
| Piotroski F-Score | 5/9 | |||||
| Altman Z-Score | 10.58 | |||||
| Beneish M-Score | -2.95 | |||||
| WACC vs ROIC | ||||||
Growth Rank
7/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | -26.4 | |||||
| 3-Year EBITDA Growth Rate | -89.7 | |||||
| 3-Year EPS without NRI Growth Rate | -49.4 | |||||
| 3-Year FCF Growth Rate | -32.2 | |||||
| 3-Year Book Growth Rate | -14.5 | |||||
| Future 3-5Y EPS without NRI Growth Rate | -2.56 | |||||
| Future 3-5Y Total Revenue Growth Rate | 31.38 |
Momentum Rank
1/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 39.44 | |||||
| 9-Day RSI | 42.58 | |||||
| 14-Day RSI | 44.12 | |||||
| 6-1 Month Momentum % | -31.04 | |||||
| 12-1 Month Momentum % | -56.19 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.08 | |||||
| Quick Ratio | 5.49 | |||||
| Cash Ratio | 4.58 | |||||
| Days Inventory | 305.03 | |||||
| Days Sales Outstanding | 67.13 | |||||
| Days Payable | 195.11 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Average Share Buyback Ratio | -4.8 | |||||
| Shareholder Yield % | -39.07 |
Profitability Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 66.35 | |||||
| Operating Margin % | -117.8 | |||||
| Net Margin % | -121.95 | |||||
| FCF Margin % | -97.15 | |||||
| ROE % | -52.66 | |||||
| ROA % | -36.91 | |||||
| ROIC % | -48.04 | |||||
| ROC (Joel Greenblatt) % | -261 | |||||
| ROCE % | -41.09 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PS Ratio | 7.21 | |||||
| PB Ratio | 2.09 | |||||
| Price-to-Tangible-Book | 3.04 | |||||
| EV-to-EBIT | -5.55 | |||||
| EV-to-Forward-EBIT | -54.32 | |||||
| EV-to-EBITDA | -5.55 | |||||
| EV-to-Forward-EBITDA | -60.35 | |||||
| EV-to-Revenue | 6.5 | |||||
| EV-to-Forward-Revenue | 5.08 | |||||
| EV-to-FCF | -6.96 | |||||
| Price-to-Median-PS-Value | 0.81 | |||||
| Price-to-Net-Current-Asset-Value | 4.05 | |||||
| Price-to-Net-Cash | 6.08 | |||||
| Earnings Yield (Greenblatt) % | -18.03 | |||||
| FCF Yield % | -11.25 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Enzymatica AB Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil €) | 3.925 | ||
| EPS (TTM) (€) | -0.025 | ||
| Beta | 0.89 | ||
| Volatility % | 30.63 | ||
| 14-Day RSI | 44.12 | ||
| 14-Day ATR (€) | 0.006309 | ||
| 20-Day SMA (€) | 0.12245 | ||
| 12-1 Month Momentum % | -56.19 | ||
| 52-Week Range (€) | 0.1115 - 0.30441 | ||
| Shares Outstanding (Mil) | 242.74 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 5 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Enzymatica AB Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Enzymatica AB Stock Events
| Event | Date | Price(€) | ||
|---|---|---|---|---|
| No Event Data | ||||
Enzymatica AB Frequently Asked Questions
What is Enzymatica AB(FRA:EN9)'s stock price today?
The current price of FRA:EN9 is €0.11. The 52 week high of FRA:EN9 is €0.30 and 52 week low is €0.11.
When is next earnings date of Enzymatica AB(FRA:EN9)?
The next earnings date of Enzymatica AB(FRA:EN9) is 2025-02-18.
Does Enzymatica AB(FRA:EN9) pay dividends? If so, how much?
Enzymatica AB(FRA:EN9) does not pay dividend.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers